In The News

Clinical Announcement

We are pleased to announce that RevitalLife is participating in an Institutional Review Board (IRB) study evaluating the efficacy of stem cell and exosome therapies for orthopedic indications, with particular emphasis on shoulder and knee conditions.

Exosome Research Updates

Stem Cell Research Updates